Add this topic to your myFT Digest for news straight to your inbox
Race for an effective shot has stoked debate on price and how to support poorer countries
Members of billionaire Sackler family to pay $225m in related civil settlement
Beijing has promised to help developing world but regulatory and logistical hurdles loom
Up to 90 fit people aged 18-30 in London will be deliberately infected with virus in effort to accelerate vaccine development
The FT is working with the Wellcome Trust to raise awareness of a growing threat
Corticosteroids have proved their worth. Monoclonal antibodies may be next
Efforts to counter ‘vaccine nationalism’ are shifting the balance of power in the drugs market
Coronavirus has highlighted the vital role of the ‘eyes and ears of healthcare’
Short-termism, market failures and misinformation are hampering efforts to prepare
Manufacturers struggle to meet surge in demand before northern hemisphere winter
Drugmaker Gilead was briefed on poor results of study before signing European deal, officials say
Results of highly anticipated Solidarity trial strike blow to hopes for coronavirus treatments
‘If you look at the curves going up everywhere, relying on PCR alone will not work’
Unemployment is rising but holding out for a vaccine to end the pain could mean a long wait
Johnson & Johnson and Eli Lilly announce pauses in blow to hopes for pandemic remedy
All of the swagger of the speciality pharma group has disappeared
Direct and indirect costs of mental illness exceed $3tn a year and are predicted to grow due to coronavirus
Democratic House speaker further politicises the race to develop a preventive treatment for coronavirus
Early signs are promising but there will be limits on how much the drug companies can charge
President’s championing of novel therapy thrusts biotech group into uncomfortable spotlight
Beijing says it will support programme that aims to provide 2bn coronavirus vaccinations
Administration has tried to restrict practice of using aborted human tissue for scientific studies
The UK prime minister’s crude characterisation of how drug innovation works has worrying implications
Company has right under contract to declare pandemic over by July 2021
International Edition
